Acamptas 333 Tablet

  • ₹ 68.85 ₹ 81

Acamptas 333 Tablet is used along with counseling and social support to help patients who are dependent on alcohol to abstain from drinking alcoholic drinks.

Seller: Jain Pharmacy

What is Acamptas 333 Tablet?

Acamptas 333 Tablet is a medicine that is used to stop craving in people who have completely stopped drinking alcohol. However, this medicine does not treat alcohol withdrawal symptoms or prevent the harmful effects of alcohol abuse.

What are the uses Acamptas 333 Tablet?

Acamptas 333 Tablet is used for treating,

  • Alcohol addiction

How to Use Acamptas 333 Tablet?

  • Normally take Acamptas 333 Tablet exactly as your doctor has told you.
  • Do not crush or chew the tablet.
  • Put it in your mouth but do not swallow it.
  • Do not handle the tablets with wet hands.

If you forget to take Acamptas 333 Tablet

  • Take your Acamptas 333 Tablet at the next scheduled time if you miss a dose and it is close to the next scheduled dose.
  • Do not take a double dose to make up for the one you missed.

If you take more Acamptas 333 Tablet

  • Contact your doctor immediately or visit the nearest hospital if you are taking more than the recommended tablet.
  • These effects usually wear off in a few hours.

If you stop taking Acamptas 333 Tablet

  • Until your doctor advises you to do so, do not stop taking this medicine.

Warning & Precautions of Acamptas 333 Tablet?

Talk to your doctor if you:

  • Have any allergy.
  • During pregnancy.
  • Are alcoholic.
  • Have kidney or liver problem..
  • During breastfeeding.

What are the side effects of Acamptas 333 Tablet?

  • Diarrhea
  • Decreased libido
  • Itching
  • Flatulence
  • Impotence
  • Abdominal pain
  • Nausea
  • Vomiting

More Information :

  • Keep Acamptas 333 Tablet out of the reach of kids.
  • Store at room temperature away from moisture, heat, and light (15-25°C).
  • Do not take this medicine after the expiry date.  
  • Take Asprito 5 medicine in the dose and duration as advised by your doctor.
read more